Stay updated on Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial

Sign up to get notified when there's something new on the Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2 (replacing v3.3.1). This is a versioning detail and does not affect the study details or functionality.
    Difference
    0.0%
    Check dated 2025-12-01T17:38:20.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and Revision: v3.2.0 was removed.
    Difference
    0.0%
    Check dated 2025-11-24T14:42:01.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A banner containing a notice about government funding lapse and NIH operating status was removed from the page. The removed text directed users to cc.nih.gov and opm.gov and did not pertain to the study details.
    Difference
    0.3%
    Check dated 2025-11-17T06:50:36.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    MAINTAIN (NCT02632045) results have been posted and the study status updated to Completed. Enrollment and site details reflect the final data.
    Difference
    0.4%
    Check dated 2025-11-03T01:17:51.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    New operating-status notice and v3.2.0 release; prior v3.1.0 revision removed.
    Difference
    2%
    Check dated 2025-10-05T10:06:46.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Updated to Revision v3.1.0 and removal of multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating content pruning in the drug-safety area and a new version tag.
    Difference
    0.3%
    Check dated 2025-09-28T03:16:32.000Z thumbnail image

Stay in the know with updates to Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ribociclib Efficacy After CDK4/6 Inhibit Progression Clinical Trial page.